Preliminary Program: Wednesday, May 20
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
7:30 a.m.-5 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 71-76
8 a.m.-5 p.m.
CME Course 80
9 a.m.-10:30 a.m.
Case Conferences (Open to APA members only)
CC05. To Be Announced
CC06. To Be Announced
Debate/Roundtable
DR03. To Be Announced
Lecture
L20. Overcoming the Terror Death Irvin Yalom, M.D., Distinguished Psychiatrist Lecture
Small Interactive Sessions
SI11. Clinical Manual for the Diagnosis and Treatment of Psychotic DepressionAnthony Rothschild, M.D. (Meet the Author)
9 a.m.-10:30 a.m.
Component Workshops
CW19. Immigrant Mental Health: Challenges and Considerations APA/SAMHSA and APA/AstraZeneca Minority Fellowships; Chair: Shirin Ali, M.D., Co-Chair: Felicia Kuo, B.A.
CW20. National Trends in Psychotherapy by Psychiatrists APA Committee on Psychotherapy by Psychiatrists; Chair: Eric Plakun, M.D.
CW21. Traditional and Psychiatric Healers in North America APA Committee of American Indian, Alaska Native, and Native Hawaiian Psychiatrists; Chair: Mary Roessel, M.D.
CW22. School Bullying: Psychiatric and Physical Health Risks and Treatment Interventions APA Corresponding Committee on Mental Health and Schools; Chair: Marcia Slattery, M.D.
CW23. Breaking Through a Shatter-Proof Glass Ceiling: What Keeps Women Psychiatrists From Reaching Their Leadership Goals? APA Committee on Women; Chair: Claudia Reardon, M.D., Co-Chair: Stacey Burpee, D.O.
Issue Workshops
IW39. Supervision in the Psychiatric Emergency Department: Techniques for Maximizing the Supervisor-Trainee Interaction Chair: Divy Ravindranath, M.D., Co-Chair: Erick Hung
IW40. Patient Suicide During Psychiatry Residency: A Workshop Discussion Chair: Christina Mangurian, M.D., Co-Chair: Andrew Booty, M.D.
IW41. Pediatric Grief and Bereavement: Strategies to Help Kids and Parents Cope Chair: Ruth Geller, M.D. (APA/Shire Fellow), Co-Chair: Eva Szigethy, M.D.
IW42. Practical Models for Incorporating EBM Into Academic Clinical Practices Chair: John Young, M.D.
IW43. Promoting Scholarship and Leadership During Residency Training Chair: Anu Matorin, M.D., Co-Chair: Sandra Sexson, M.D.
IW44. Beyond Doctor-Patient Relationship in Cyberspace: Pitfalls, Transgressions, and Guidelines (When Therapists and Patients Google Each Other) Chair: Damir Huremovic, M.D., Co-Chair: Nyapati Rao, M.D.
IW45. Older Adults and the Neurobiology of Substance Abuse National Institute on Drug Abuse; Chair: Timothy Condon, Ph.D.
IW46. American Board of Psychiatry and Neurology Update: Certification in Psychiatry and Its Subspecialties Chair: Larry Faulkner, M.D., Co-Chair: Naleen Andrade, M.D.
IW47. The Cobbler's Children: Dealing With Psychiatric Problems in Our Own Families Chair: Julia Frank, M.D.
IW48. Oral Boards Boot Camp—2009 Chair: Elyse Weiner, M.D., Co-Chair: Eric Peselow, M.D.
IW49. How to Launch a Successful Private Practice (Part 1) Chair: William Callahan, M.D.
IW50. Psychiatrists Who Have Had a Psychiatric Illness: Their StoriesChair: Michael Myers, M.D., Co-Chair: Leah Dickstein, M.D.
9 a.m.-12:30 p.m.
Media Workshops
MW5. “The Bridge” (A Documentary Film About Suicide From the Golden Gate Bridge; Discussion With the Film's Director and a Bridge Jump Survivor) (Open to APA members only) APA Northern California Psychiatric Society; Chair: Mel Blaustein, M.D., Co-Chair: Raymond Zablotny, M.D.
MW6. “disFIGURED”—A Movie About Women and Weight—The Impact of Appearance on Coping With LifeChair: Katherine Halmi, M.D., Co-Chair: Seymour Gers, M.D.
9 a.m.-4 p.m.
CME Courses 77-79
10 a.m.-5 p.m.
APA Member Center Open Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Advances In Medicine
AM03. Medical Updates and Controversies: What Psychiatrists Should Know Robert McCarron, D.O.
Lecture
L21. Developments in Mental Health Services in India Matthew Varghese, M.D., International Lecture
Forums
F08. APA and WPA Chair: Pedro Ruiz, M.D.
F09. The Milestones of Recovery Scale: Tracking Recovery and Guiding Services Chair: Mark Ragins, M.D.
Small Interactive Sessions
SI12. How to Research a Clinical Question Ranga Krishnan, M.D.
SI13. How to Treat Behavioral Symptoms in Dementia Marc E. Agronin, M.D.
Component Workshops
CW24. Psychiatric Residency Training Needs for International Medical Graduates APA Committee on International Medical Graduates; Chair: Antony Fernandez, M.D.
CW25. Motivating the Motivators: Motivational Enhancement Therapy Made Easy APA Corresponding Committee on Training and Education in Addiction Psychiatry; Chair: Syed Sattar, M.D.
CW26. The Assessment of Violence Risk APA Council on Psychiatry and Law; Chair: Alec Buchanan, Ph.D.
Issue Workshops
IW51. The Post 9/11 Era: Understanding the Cultural Issues in the Psychiatric Treatment of Muslim Patients APA Illinois Psychiatric Society; Chair: Nancy Abdel-Wahab, M.D., Co-Chair: Nafisa Ghadiali, M.D.
IW52. Visual Recognition of Catatonia: Video Teaching Session Chair: Andrew Francis, M.D.
IW53. Watching the Movies, Beating the Stigmas Chair: Rudolf Feijen, M.D.
IW54. Psychotherapy Update: A Review of the Current Literature for the Practicing Psychiatrist Chair: Priyanthy Weerasekera, M.D., Co-Chair: John Manring, M.D.
IW55. Developing a Mental Health Court for Domestic Violence Perpetrators: A New Judicial Model Chair: Lawrence Richards, M.D., Co-Chair: Bruce J. Winick, M.D.
IW56. “Doctor, Is That a Baby You Are Carrying?”: Impact of Physician Pregnancy on the Therapeutic Alliance Chair: Sudeepta Varma, M.D., Co-Chair: Jamae Campbell, M.D.
Scientific and Clinical Reports
Session 17. Borderline Personality Disorder
49. Parental Viewpoints of Trajectories to Borderline Personality Disorder Marianne Goodman, M.D.
50. Lifetime Patterns of Psychotherapy and Medication Utilization in Females With Borderline Personality Disorder: Results of an Online Parental Survey Marianne Goodman, M.D.
51. Is Borderline Personality Disorder Underdiagnosed? David Meyerson, B.A.
Session 18. Algorithms and Other Models in the Treatment of Depression
52. Using the Chronic Care Model to Improve Depression Care on College Campuses Henry Chung, M.D.
53. CBASP and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression James Kocsis
54. Can Clinicians Improve Antidepressant Remission Rates With Better Treatment Algorithms? Richard Metzner, M.D.
Session 19. Premorbid Factors and Course in Schizophrenia
55. Remission in Schizophrenia: A National Survey of Clinical and Psychosocial Aspects Yoram Barak, M.D., M.H.A.
56. Schizophrenia in the Offspring of Antenatally Depressed Mothers in the Northern Finland 1966 Birth Cohort—A Gene X Environment Interaction Pirjo H. Maki, M.D., Ph.D.
57. Child and Adolescent Symptoms Predicting Psychosis Juha M. Veijola, M.D.
Session 20. Trauma and PTSD
58. The USS Cole Bombing: Analysis of Preexisting Factors as Predictors for Development of Posttraumatic Stress Disorder Kevin Nasky, D.O.
59. Emotional Distress and Other Health-Related Dimensions Among Elderly Survivors of the Shoa Living in the Community Robert Kohn, M.D.
60. Psychopathology Among Holocaust Survivors 60 Years Thereafter Itzhak Levav, M.D., M.S.
Session 21. Suicide in Specially Defined Populations
61. Suicide Among Female Veterans During 2005: Findings From the National Violent Death Reporting System Bentson McFarland, M.D., Ph.D.
62. A Multi-Site Study of the Incidence and Nature of Inpatient Suicide Attempts Virginia L. Susman, M.D.
63. Association Between Antidepressant Half-Life and the Risk of Suicidal Ideation or Behavior Among Children and Adolescents Eric Smith, M.D., M.P.H.
Session 22. Substance Use Disorder in Psychoses and Bipolar Disorder
64. Cannabis Withdrawal in People With Schizophrenia David Gorelick, M.D., Ph.D.
65. Is Use of Illegal Non-Cannabinoid Substances Associated With Psychotic Symptoms? Nina Kuzenko, M.D.
66. Comorbid Anxiety and Substance Use Disorders Confound the Clinical Diagnosis of Bipolar I But Not II: Implication for Mood Stabilizer Use Keming Gao, M.D., Ph.D.
Session 23. Epidemiology
67. Survey of World Psychiatric Association (WPA) Member Societies on Child Sexual Abuse and Physician-Patient Sexual Relations Donna Stewart, M.D.
68. Parental Mental Illness and Sudden Infant Death Syndrome: The Role of Maternal Smoking, Obstetric Risk Factors, and Social Adversity Roger Webb, Ph.D., M.S.C.
69. SMI, SPMI, SED, FMD: Why Can't We Use Only One Mental Health Indicator? Deepak Prabhakar, M.D., M.P.H.
Session 24. Metabolic Effects of Psychotropic Medication
70. Do Cardiovascular Risk Factors Impede Antidepressant Treatment Response? Dale D'Mello, M.D.
71. Depressive Symptoms and Risk for 10-Year Cardiovascular Morbidity and Mortality Hannu Koponen, M.D., Ph.D.
72. Weight Gain and Increases in Cholesterol, Triglyceride, and Glucose Levels in Schizophenia Patients Treated With Clozapine, Olanzapine, and Haloperidol Menahem Krakowski, M.D., Ph.D.
Noon-2 p.m.
New Research Posters
2 p.m.-5 p.m.
Advances In Series
A08. Hospital Psychiatry Steven Sharfstein, M.D.
Presidential Symposia
PS04. When the Treatment Fails the Patient: Psychodynamic Contributions to the Treatment of Refractory Patients Chair: Sherry Katz-Bearnot, M.D.
PS05. The Invisible Wounds of War: Mental Health Needs of Returning Military and Their Families Chair: Carolyn Robinowitz, M.D.
PS06. The Grandkids of the 1967 Flower Children: Lessons From Haight-Ashbury and From Treatment and Recovery Chair: Mark Gold, M.D.
PS07. Suicide and the Golden Gate Bridge Chair: Mel Blaustein, M.D.
Lecture
L 22. What Research Tells Us About Suicide Paula Clayton, M.D., Distinguished Psychiatrist Lecture
Symposia
S37. Disability Reduction and Rehabilitation of Iraq and Afghanistan War Veterans: The Role of Civilian Mental Health Providers
Suicide Prevention Among Returning Soldiers of War Donna H. Barnes, Ph.D.
Meeting the Needs of Post-Deployment Soldiers: An Interagency Approach James K. Boehnlein, M.D.
Civilian Assessment of Veterans of Iraq and Afghanistan Wars Samuel O. Okpaku, M.D.
Psychological Effects of Persistent Conflict: Strategies for Mitigation and Collaboration With Civilians Elspeth C. Ritchie, M.D.
Traumatic Brain Injury, Treatment, and Rehabilitation James R. Merikangas, M.D.
The War on Terrorism: Rethinking Systems and Services for Iraq and Afghanistan Combat Soldiers and Their Families Ron E. Armstead, L.C.S.W.
S38. In-Residency Clinical Skills Assessment: Training for Faculty Evaluators APA Council on Medical Education and Lifelong Learning
Rationale for a Change in the Live-Patient Exam and Program Requirements for the In-Residency Clinical Skills Assessment Sandra B. Sexson, M.D.
What the Research on Direct Observation of Clinical Skills Tells Us Joan M. Anzia, M.D.
Clinical Skills Assessment: Competencies, Skills, Forms, and Anchor Points Richard F. Summers, M.D.
Setting Up a Curriculum for Faculty on Clinical Skills Assessment Karen Broquet, M.D.
S39. Integrating Treatment for Substance Use and Posttraumatic Stress Disorders in Patients With Co-Occurring Conditions National Institute on Drug Abuse
Treatment of Co-Occurring PTSD and Substance Use Disorders: Exposure-Based Therapy and Medication Management Kathleen Brady, M.D.
Stepped Collaborative Care Targeting PTSD and Co-Occurring Substance Use Disorders Douglas F. Zatzick, M.D.
Seeking Safety: An Evidence-Based Model for PTSD and/or Substance Abuse Lisa M. Najavits, Ph.D.
Integrating Treatment for Smoking Cessation and PTSD Andrew J. Saxon, M.D.
Pharmacologic Management of PTSD and Comorbid Alcohol Dependence Ismene L. Petrakis, M.D.
Integrated Treatment for PTSD and Substance Use Disorders in Veterans Sonja V. Batten, Ph.D.
S40. Impulse Control Disorders: Recognition and Clinical Management
Overview of Impulse Control Disorders and Their Neurobiology Eric Hollander, M.D.
Compulsive Shopping Disorder: A Review Donald W. Black, M.D.
Update on the Clinical Features and Treatment of Kleptomania Jon E. Grant, M.D.
Trichotillomania and Skin Picking—Clinical Features and Treatment Samuel R. Chamberlain, M.D.
Etiology, Identification, and Treatment of Pathological Gambling Marc N. Potenza, M.D.
S41. Recent Developments in Cross-Cultural, Ethnic, and Ethnopsychopharmacological Aspects of Mood Disorders: A Global Perspective
Ethnopsychopharmacology Update David C. Henderson, M.D.
Psychiatric Management of Hispanic Patients: Cross-Cultural Issues and Ethnopsychopharmacology David Mischoulon, M.D.
Culturally Sensitive Collaborative Treatment (CSCT) for Chinese Americans With Depression Albert Yeung, M.D.
Mood Disorders in the Asian-Indian Population: Effects of Culture, Globalization, and Ethnopsychopharmacology Rajesh M. Parikh, M.D.
Mood Disorders in Women: The Interaction of Culture and Biopsychosocial Factors Shamsah B. Sonawalla, M.D.
S42. Choosing the Right Treatment for Substance Abuse
Choosing the Right Treatment for Cocaine Dependence Adam Bisaga, M.D.
Choosing Treatment for Cannabis Dependence Frances R. Levin, M.D.
Integrating Psychosocial Interventions With Medications in the Treatment of Substance Dependence Edward V. Nunes, M.D.
Pain and Addiction: Implications of Substance Use Disorders for Opioid Therapy Maria Sullivan, M.D.
Choosing the Right Treatment for Opioid Dependence Herbert D. Kleber, M.D.
S43. Suicide and Aggression: A Practical Toolkit From Risk Assessment to Joint Commission to the Patient APA Committee on Patient Safety
From Rules to Protocols: Suicide Risk Assessment in Everyday Practice Geetha Jayaram, M.D.
Practical Approaches to Violence Risk Assessment Marvin S. Swartz, M.D.
SAFE-T Suicide Assessment Five-step Evaluation and Triage Douglas G. Jacobs, M.D.
Suicide Risk Management: Research and Practice in an Inpatient Department of Suicide Prevention (Psychiatric University Clinic Salzburg–Austria) Reinhold Fartacek, M.D.
The Joint Commission's View of the Response and Prevention of Suicide and Aggression Robert Wise, M.D.
S44. The Role of Forensic Psychiatry in Evaluating Problematic Internet Behaviors—Untangling Webs of Deceit From Murder to Malpractice
Internet Addictions Michael Harlow, M.D., J.D.
Evaluation of Child Pornography Possession Humberto D. Temporini, M.D.
Assessment of Internet Bullying Jennifer Chaffin, M.D.
Cyberstalking Soroush Mohandessi, M.D.
Malpractice and CyberCare Charles Scott, M.D.
S45. Drop “Schizophrenia”? International Perspectives World Psychiatric Association's Section on Rehabilitation and Section for Psychosocial Rehabilitation
Should We Abandon the Term Schizophrenia After all These Years? John A. Talbott, M.D.
Beyond the Term Schizophrenia Afzal Javed, M.B.B.S.
Japan: Experience Since Schizophrenia Was Renamed in 2002 Naotaka Shinfuku, M.D.
Western Pacific Perspectives on Schizophrenia Luis Faustino Ignacio, M.D.
To Be Announced Russell D'Souza, M.D.
Subtypes, Electrophysiological Data Point to Several Different Diseases Zebulon Taintor, M.D.
S46. Lesbian, Gay, Bisexual, and Transgender Youth: Family Approaches
Mental Health and Health Outcomes for GLBT Youth and Young Adults: The Role of Family Support Caitlin Ryan, Ph.D.
Psychopathology and Gender Variance in a Clinical Sample of Children Edgardo J. Menvielle, M.D.
Gender Made, Gender Nurtured, Gender Bent: The Child Shapes the Parent as the Parent Shapes the Child in Families With a Gender-Variant Child Diane Ehrensaft, Ph.D.
Three Integrated Family Interventions for Children With Gender-Variant Behaviors: Face-To-Face Groups, Online Discussions, and Multi-Family Gatherings Catherine L. Tuerk, M.A.
S47. Personality Disorders in the United States: Relationship to Early Experiences, Occurrence, and Course of Axis I Disorders National Institute on Alcohol Abuse and Alcoholism
Relationship of Personality Disorders to Course of Mood and Anxiety Disorders in a National Sample Andrew E. Skodol, M.D.
Personality Disorders: Their Impact on the Course of Alcohol and Drug Dependence in the U.S. General Population Deborah S. Hasin, Ph.D.
Childhood Abuse and Neglect Associated With Personality Disorders Jeffrey Johnson, Ph.D.
Empirically Derived Mental Disorder Spectrums and Case Conceptualization: The Role of Personality in Linking Axes I and II Robert Krueger, Ph.D.
S48. Spiritually Integrated Treatment
Therapeutic Uses of a Shared Tradition to Address Problematic Faith Nadine J. Nyhus, M.D.
Spiritually Integrated Treatment Yousef Abouallaban, M.D.
Mental Health Promotion in the African-American Faith Community Michael A. Torres, M.D.
Spiritual Interventions in the Treatment of Depression John R. Peteet, M.D.
S49. How to Approach the Pregnant Patient From a Mental Health Standpoint
Diagnosis and Prognosis of Mood Disorders During Pregnancy and the Postpartum Period Adele Viguera, M.D.
Prevention and Treatment of Psychiatric Disorders During Pregnancy Gail E. Robinson, M.D.
Medicating the Depressed Pregnant Woman: Risk-Benefit Discussions and the Informed-Consent Process Margaret Spinelli, M.D.
Staying Informed and Afloat: The Importance of Evidence-Based Clinical Practice in the Treatment of Mentally ill Patients During and After Pregnancy Elizabeth M. Fitelson, M.D.
S50. Advances in Electroconvulsive Therapy APA Corresponding Committee on ECT and Other Electromagnetic Therapies
Ultra-Brief Pulse ECT: Efficacy and Cognitive Impact—Findings From the United States Joan Prudic, M.D.
Ultra-Brief Pulse ECT: Efficacy and Cognitive Impact—Findings From a Larger Clinical Sample (Sydney) Colleen K. Loo, M.B.B.S.
Comparing Bifrontal, Bitemporal, and Right Unilateral Electrode Placement in ECT: A Multisite Study From the Consortium for Research in ECT (CORE) Charles Kellner, M.D.
An Update on Continuation-ECT Husain Mustafa, M.D.
S51. Integrated Treatment of Personality Disorder: Principles and Technique
Principles for Organizing Integrated Treatment for Personality Disorder John Livesley, M.D.
Tailoring Common Treatment Principles to Fit Individual Personalities Kenneth L. Critchfield, Ph.D.
An Integrated View of Therapy Techniques for Personality Disorders John F. Clarkin, Ph.D.
Integrated Treatment for Personality Disorder With Prominent Inhibited/Constricted Traits Giuseppe Giancarlo Dimaggio, M.D.
S52. “Me-Too” Medications, Really? APA Council on Global Psychiatry and the APA Council on Children, Adolescents, and Their Families
Barriers to Innovation in Psychopharmacology of Schizophrenia William T. Carpenter, M.D.
Diagnosis and Treatment of Bipolar Disorder Frederick Goodwin, M.D.
Pharmacology Leading to the Current Debates About Old and New Psychotropics Alan F. Schatzberg, M.D.
Concept of “Me-Too” Medications on Public Policies Roger Peele, M.D.
Pharmacologic Treatment of Depression Jan Fawcett, M.D.
S53. End of Life Care: A Multidisciplinary Clinical and Research Update
Psychiatry and Palliative Medicine Collaboration at the End of Life Michael W. Rabow, M.D.
Issues Facing Caregivers and Family at the End of Life Dianne M. Shumay, Ph.D.
Psychological Adjustment to End of Life Losses: Application of the Reintegration Model to Advanced Cancer Sara J. Knight, Ph.D.
End of Life Care in Dementia: A Research Update Laura B. Dunn, M.D.
Legal and Ethical Issues at the End of Life in Chronically Mentally Ill Patients With HIV/AIDS Jeanne M. St. Pierre, M.D.
S54. Engaging and Treating Persons With Recent-Onset Schizophrenia: Practice-Based Evidence From the Clinical Trenches American Association of Community Psychiatrists
Working in the Trenches With 18- to 25-Year-Olds Mark Ragins, M.D.
Assisting the Transition From Child Mobile Treatment to Adult ACT Services for Adolescents With Schizophrenia Curtis N. Adams Jr., M.D.
The Dance of Engagement: Connecting With Young Adults in the Pursuit of Mental Health Andrew J. McLean, M.D.
Early Assessment and Support Team: A Community-Based Clinical Team Focused on Identfying, Engaging, and Treating Youth Who Are Developing Psychosis Robert Wolf, M.D.
S55. Sleep Disturbances and Circadian Disruptions Affecting, and Affected by, Addiction to Drugs National Institute on Drug Abuse
Differential Roles for Individual Circadian Genes in Bipolar Disorder and Drug Addiction Colleen A. McClung, Ph.D.
Disordered Sleep and Proinflammatory Cytokines in Cocaine Dependence: Clinical Implications Michael R. Irwin, M.D.
4-Methyleneldioxymethamphetamine (MDMA, Ecstasy) Use Is Associated With Sleep-Disordered Breathing Una D. McCann, M.D.
Impact of Sleep Deprivation and Insomnia on the Development and Maintenance of Drug Addiction Scott E. Lukas, Ph.D.
“Occult Insomnia” and Abstinence From Cocaine: Implications for Cognitive Function and the Clinical Treatment of Cocaine Dependence Robert T. Malison, M.D.
3 p.m.-5 p.m.
New Research Poster Session 7
7 p.m.-10 p.m.
Industry-Supported Symposia ▪
Information & Authors
Information
Published In
History
Published online: 20 February 2009
Published in print: February 20, 2009
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).